参考文献/References:
[1] Anιk A, Catlι G, Abac A, et al. Maturity-onset diabetes of the young(MODY): an update[J].J Pediatr Endocrinol Metab,2015,28(3-4):251-263. DOI: 10.1515/jpem-2014-0384.
[2] 刘丽梅.青少年的成人起病型糖尿病的特点、基因诊断与转化医学[J].中华糖尿病杂志,2014,6(1):5-9. DOI:10.3760/cma.j.issn.1674-5809.2014.01.002.
[3] 沈云峰,翁建平.葡萄糖激酶基因突变与功能学研究进展[J].国际内科学杂志,2008,35(12):692-695.
[4] Chakera AJ, Steele AM, Gloyn AL,et al. Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation[J].Diabetes Care,2015,38(7):1383-1392. DOI: 10.2337/dc14-2769.
[5] Froguel P, Vaxillaire M, Sun F,et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus[J].Nature,1992,356(6365):162-164.
[6] Stride A, Vaxillaire M, Tuomi T,et al. The genetic abnormality in the beta cell determines the response to an oral glucose load[J].Diabetologia,2002,45(3):427-435.
[7] 李秀珍,刘丽,梁翠丽,等.青少年发病的成年型糖尿病2型一家系[J].中华儿科杂志,2014,52(11):867-871. DOI:10.3760/cma.j.issn.0578-1310.2014.11.017.
[8] 王志新,于淼,郑佳,等.四例中国青少年的成人起病型糖尿病2型家系的临床与分子遗传学研究[J].中华糖尿病杂志,2014,6(1):21-26. DOI:10.3760/cma.j.issn.1674-5809.2014.01.005.
[9] Bacon S, Schmid J, McCarthy A,et al. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young[J].Am J Obstet Gynecol,2015,213(2):236.e1-e7. DOI: 10.1016/j.ajog.2015.04.037.
[10] 王晓春,徐克前,刘惠宁,等.胎儿宫内生长受限与胰岛素样生长因子-Ⅱ关系的研究[J].中国妇幼保健,2002,17(6):368,383. DOI: 10.3969/j.issn.1001-4411.2002.06.023.
[11] 朱明慧.血胰岛素及C肽与胎儿生长发育关系的研究[D].中山大学,2006.
[12] Colom C, Corcoy R. Maturity onset diabetes of the young and pregnancy[J].Best Pract Res Clin Endocrinol Metab,2010,24(4):605-615. DOI: 10.1016/j.beem.2010.05.008.
[13] Steele AM, Shields BM, Wensley KJ,et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia[J].JAMA,2014,311(3):279-286. DOI: 10.1001/jama.2013.283980.
[14] Pruhova S, Dusatkova P, Kraml PJ,et al. Chronic mild hyperglycemia in GCK-MODY patients does not increase carotid intima-media thickness[J].Int J Endocrinol,2013,2013:718254. DOI: 10.1155/2013/718254.
[15] Spégel P, Ekholm E, Tuomi T,et al. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene(MODY2)[J].Diabetes,2013,62(2):653-661. DOI: 10.2337/db12-0827.
[16] Ellard S, Bellanné-Chantelot C, Hattersley AT,et al. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young[J]. Diabetologia,2008,51(4):546-553. DOI: 10.1007/s00125-008-0942-y.
[17] Gandica RG, Chung WK, Deng L,et al. Identifying monogenic diabetes in a pediatric cohort with presumed type 1 diabetes[J].Pediatr Diabetes,2015,16(3):227-233. DOI: 10.1111/pedi.12150.
[18] Stride A, Shields B, Gill-Carey O,et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia[J]. Diabetologia,2014,57(1):54-56. DOI: 10.1007/s00125-013-3075-x.
[19] Ellard S, Beards F, Allen LI,et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria[J].Diabetologia,2000,43(2):250-253.
[20] Chakera AJ, Spyer G, Vincent N,et al. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort[J].Diabetes Care,2014,37(5):1230-1236. DOI: 10.2337/dc13-2248.
[21] Hindmarsh PC, Geary MP, Rodeck CH,et al. Intrauterine growth and its relationship to size and shape at birth[J].Pediatr Res, 2002,52(2):263-268.
[22] Chakera AJ, Carleton VL, Ellard S,et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment[J].Diabetes Care,2012,35(9):1832-1834. DOI: 10.2337/dc12-0151.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(03):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(03):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(03):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(03):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(03):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(03):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(03):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(03):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]